Showing results (241-250 of 288) with videos related to
Sort By:
Pageof 29
Oncogene|July 12, 2018
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomasManfred Kunz, Henry Löffler-Wirth, Michael Dannemann, et al.European Journal of Cancer (Oxford, England : 1990)|June 11, 2017
Prognostic factors and treatment outcomes in 444 patients with mucosal melanomaMarkus V Heppt, Alexander Roesch, Benjamin Weide, et al.The British Journal of Dermatology|February 20, 2026
Melanoma of unknown primary shows oncogenic pattern and clinical course of sun-exposed melanomaGeorg Lodde, Jonida Dollani, Wolfgang Galetzka, et al.Science (New York, N.Y.)|September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanomaEliezer M Van Allen, Diana Miao, Bastian Schilling, et al.International Journal of Cancer|July 8, 2024
Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADORegSebastian A Wohlfeil, Leonie Kranzmann, Christel Weiß, et al.Journal of Clinical Medicine|May 16, 2020
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional TrialTheresa Steeb, Anja Wessely, Dagmar von Bubnoff, et al.European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibitionMarkus V Heppt, Lucie Heinzerling, Katharina C Kähler, et al.Frontiers of Medicine|July 11, 2023
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trialElias A T Koch, Anne Petzold, Anja Wessely, et al.European Journal of Cancer (Oxford, England : 1990)|December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapyCarl M Thielmann, Johanna Matull, Anne Zaremba, et al.European Journal of Cancer (Oxford, England : 1990)|April 18, 2018
Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOGUwe Hillen, Ulrike Leiter, Sylvie Haase, et al.Pageof 29